1. Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma
   Takeshi Imakura et al, 2022, Internal Medicine CrossRef
2. Interstitial Lung Disease Induced by Pazopanib Treatment
   Shotaro Ide et al, 2017, Internal Medicine CrossRef
3. Lenvatinib-induced severe interstitial pneumonia in a patient with hepatocellular carcinoma: A case report
   Yuki Ikeda et al, 2021, Kanzo CrossRef
4. Cyclodextrin polymers as nanocarriers for sorafenib
   Valentina Giglio et al, 2018, Investigational New Drugs CrossRef
5. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma
   Kohei Kotani et al, 2019, Clinical Journal of Gastroenterology CrossRef
6. Anticancer therapy and lung injury: molecular mechanisms
   Li Li et al, 2018, Expert Review of Anticancer Therapy CrossRef
7. Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan
   Tomoko Funahashi et al, 2021, Drug Safety CrossRef